We are live on ! Find out more
MBOT icon

Microbot Medical

32 hedge funds and large institutions have $1.41M invested in Microbot Medical in 2023 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

700% more call options, than puts

Call options by funds: $16K | Put options by funds: $2K

133% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 3

14% more funds holding

Funds holding: 2832 (+4)

1.99% less ownership

Funds ownership: 10.56%8.57% (-2%)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

58% less capital invested

Capital invested by funds: $3.36M → $1.41M (-$1.95M)

Holders
32
Holders Change
+4
Holders Change %
+14.29%
% of All Funds
0.51%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
4
Reduced
6
Closed
3
Calls
$16K
Puts
$2K
Net Calls
+$14K
Net Calls Change
-$1K

MBOT Hedge Fund Activity: Q3 2023 in Review

32 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Microbot Medical (MBOT) for Q3 2023, worth a combined $1.41M — down 58% from $3.36M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new MBOT positions and 3 closed out — a net gain of 4 holders — while 4 added to existing stakes and 6 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $112K. The largest seller was Armistice Capital, exiting entirely with an estimated $1.05M sold.

  • 32 institutional investors held Microbot Medical (MBOT) as of Q3 2023, up from 28 in Q2 2023.
  • Funds reported $1.41M of Microbot Medical stock for Q3 2023, down 58% quarter-over-quarter.
  • 7 funds opened new Microbot Medical positions in Q3 2023 and 3 closed out, a net change of +4 holders.
  • The largest Microbot Medical buyer in Q3 2023 was Citadel Advisors, an estimated $112K added.
  • The largest Microbot Medical seller in Q3 2023 was Armistice Capital, an estimated $1.05M sold.

Based on aggregated 13F filings for Q3 2023.